Induction of complete remission using single agent clofarabine in a patient with primary refractory acute myeloblaste leukemia.
D000227:Adenine Nucleotides; D000328:Adult; D000970:Antineoplastic Agents / Q000627:therapeutic use*; D001087:Arabinonucleosides / Q000627:therapeutic use*; D002986:Clinical Trials as Topic; D000077866:Clofarabine; D019008:Drug Resistance, Neoplasm; D006801:Humans; D015470:Leukemia, Myeloid, Acute / Q000188:drug therapy*; D008297:Male; D009705:Nucleosides / Q000737:chemistry; D011379:Prognosis; D011687:Purines / Q000737:chemistry; D012074:Remission Induction
D000227:Adenine Nucleotides; D000970:Antineoplastic Agents; D001087:Arabinonucleosides; D009705:Nucleosides; D011687:Purines; D000077866:Clofarabine